Atlas Trials

Efficacy of Low-dose Interleukin-2 Treatment in Chronic Spontaneous Urticaria

Clinical trial NCT04893980 · UNKNOWN

Trial details

NCT number
NCT04893980
Sponsor
Second Xiangya Hospital of Central South University
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chronic Spontaneous Urticaria
Start date
2021-06-16
Primary completion
2022-06-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.